Prof Jörn Schattenberg presents: Emerging Role of the Hepatic Thyroid Hormone Pathway in the Pathophysiology of NASH as presented at EASL ‘23: NASH: A Growing Unmet Therapeutic Need
Melody.education: Educational programs on Nonalcoholic Steatohepatitis (NASH) and Nonalcoholic Fatty Liver Disease (NAFLD)
00:00
Understanding the Growing Burden of NASH and Advances in Diagnosis
This chapter explores the rising prevalence of Nonalcoholic Steatohepatitis (NASH) and its impact on mortality. It emphasizes the importance of accurate diagnosis, management strategies, and advancements in non-invasive testing for better patient outcomes.
Transcript
Play full episode
